Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jong Sung Kim, MD, Phd
Department of Neurology, Asan Medical Center, Seoul, South Korea
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pusan National University Hospital
Busan, South Korea
- Kyungpook National University Hospital
Daegu, South Korea
- Myongji Hospital
Gyeonggi-do, South Korea
- Inje University Busan Paik Hospital
Pusan, South Korea
- Asan Medical Center, University of Ulsan
Seoul, South Korea
- Korea University Guro Hospital
Seoul, South Korea
- Kyunghee University Medical Center
Seoul, South Korea
- Soonchunhyang University Hospital
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jun 2016
- Primary completion
- 30 May 2017
- Completion
- 22 Aug 2017
- Last update posted
- 21 Jul 2020
- Registered enrollment
- 80
- Registry id
- NCT02787278
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.